These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. Wong VS; Hughes V; Trull A; Wight DG; Petrik J; Alexander GJ J Viral Hepat; 1998 May; 5(3):187-92. PubMed ID: 9658372 [TBL] [Abstract][Full Text] [Related]
3. Predictive accuracy of serum hyaluronic acid as a non-invasive marker of fibrosis in a cohort of multi-transfused Egyptian children with β-thalassaemia major. El-Shabrawi MH; Zein El Abedin MY; Omar N; Kamal NM; Elmakarem SA; Khattab S; El-Sayed HM; El-Hennawy A; Ali AS Arab J Gastroenterol; 2012 Jun; 13(2):45-8. PubMed ID: 22980590 [TBL] [Abstract][Full Text] [Related]
4. Correlation between Serum Hyaluronic Acid with Steatosis, Non alcoholic Steato-hepatitis and Fibrosis in Patients with Chronic Hepatitis C Virus Infection. Mahmoud HS; Ghweil AAS; Osman GS; Ezz-Eldin S Bazeed S; Helal MM Trop Gastroenterol; 2016; 37(2):93-100. PubMed ID: 30234278 [TBL] [Abstract][Full Text] [Related]
5. Role of hyaluronic acid and laminin as serum markers for predicting significant fibrosis in patients with chronic hepatitis B. Li F; Zhu CL; Zhang H; Huang H; Wei Q; Zhu X; Cheng XY Braz J Infect Dis; 2012; 16(1):9-14. PubMed ID: 22358349 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Guéchot J; Laudat A; Loria A; Serfaty L; Poupon R; Giboudeau J Clin Chem; 1996 Apr; 42(4):558-63. PubMed ID: 8605673 [TBL] [Abstract][Full Text] [Related]
7. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714 [TBL] [Abstract][Full Text] [Related]
8. YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection. Schiavon LL; Carvalho-Filho RJ; Narciso-Schiavon JL; Medina-Pestana JO; Lanzoni VP; Ferraz ML; Silva AE Scand J Gastroenterol; 2010 May; 45(5):615-22. PubMed ID: 20163287 [TBL] [Abstract][Full Text] [Related]
9. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis. Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050 [TBL] [Abstract][Full Text] [Related]
10. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection. Schiavon LL; Narciso-Schiavon JL; Carvalho Filho RJ; Sampaio JP; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML J Viral Hepat; 2008 Sep; 15(9):666-74. PubMed ID: 18482283 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection in Spanish volunteer blood donors: HCV RNA analysis and liver disease. Muñoz-Gómez R; García-Monzón C; García-Buey L; Lo Iacono O; Borque MJ; Garía-Sánchez A; Pajares JM; Moreno-Otero R Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):273-7. PubMed ID: 8724030 [TBL] [Abstract][Full Text] [Related]
12. Relationship between serum concetrations of type III procollagen, hyluronic acid and histopathological findings in the liver of HCV-positive blood donors. Camacho VR; Silveira TR; Oliveira JR; Barros SG; Cerski CT Arq Gastroenterol; 2007; 44(2):118-22. PubMed ID: 17962855 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2-positive blood donors. Salmerón FJ; Palacios A; Pérez-Ruiz M; Torres C; Oyonarte S; Fernández-Montoya A; Ruiz-Extremera A Dig Dis Sci; 1996 Oct; 41(10):1933-8. PubMed ID: 8888703 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection. Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132 [TBL] [Abstract][Full Text] [Related]
15. Clinical assessment and incidence of hepatitis C RNA in 50 consecutive RIBA-positive volunteer blood donors. McCaughan GW; McGuinness PH; Bishop GA; Painter DM; Lien AS; Tulloch R; Wylie BR; Archer GT Med J Aust; 1992 Aug; 157(4):231-3. PubMed ID: 1279365 [TBL] [Abstract][Full Text] [Related]
16. Liver histology in anti-HCV-positive persons with normal or minimally elevated aminotransferases. Morales TG; Sampliner RE; Bhattacharyya A; Alter MJ J Clin Gastroenterol; 1995 Dec; 21(4):301-5. PubMed ID: 8583105 [TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels. Rossini A; Gazzola GB; Ravaggi A; Agostinelli E; Biasi L; Albertini A; Radaeli E; Cariani E Transfusion; 1995 Feb; 35(2):108-11. PubMed ID: 7529954 [TBL] [Abstract][Full Text] [Related]
18. Performance of diagnostic biomarkers in predicting liver fibrosis among hepatitis C virus-infected Egyptian children. Nassef YE; Shady MM; Galal EM; Hamed MA Mem Inst Oswaldo Cruz; 2013 Nov; 108(7):887-93. PubMed ID: 24141960 [TBL] [Abstract][Full Text] [Related]
19. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. McHutchison JG; Blatt LM; de Medina M; Craig JR; Conrad A; Schiff ER; Tong MJ J Gastroenterol Hepatol; 2000 Aug; 15(8):945-51. PubMed ID: 11022838 [TBL] [Abstract][Full Text] [Related]
20. Serum hyaluronic acid as a predictor of fibrosis in chronic hepatitis B and C virus infection. Nath NC; Rahman MA; Khan MR; Hasan MS; Bhuiyan TM; Hoque MN; Kabir MM; Raha AK; Jahan B Mymensingh Med J; 2011 Oct; 20(4):614-9. PubMed ID: 22081179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]